Sassicaia Capital Advisers LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Sassicaia Capital Advisers LLC reported 7 stock positions worth $4.1 million. Its top holding was Invesco QQQ Trust Series 1 (QQQ) at 69.2% of the portfolio, followed by Moderna (MRNA, 14.6%) and Cyberark Software Ltd./Israel (CYBR, 8.1%). Compared with Q3 2024, it opened 6 new positions, sold out of 17 and added to 1. The biggest buy was Invesco QQQ Trust Series 1 (QQQ, shares +331%) and the biggest sale an exit from Apple (AAPL).
- Most Recent 13F
- Q2 2026
- Location
- JERICHO, NY
- CIK
- 0001692751
- Portfolio Value
- $4.1M (Q4 2024)
- SEC Filing
- 0001420506-25-000563 ↗ filed Feb 14, 2025
Holdings Value
Holdings 7 stocks · $4.1M
| QQQ Invesco QQQ Trust Series 1 | 69.21% | 5,600 | $2.9M | Add +330.8% |
| MRNA Moderna Inc. | 14.58% | 14,500 | $603K | New |
| CYBR Cyberark Software Ltd./Israel | 8.05% | 1,000 | $333K | New |
| X United States Steel Corp. | 6.57% | 8,000 | $272K | New |
| NRXP NRX Pharmaceuticals Inc. | 0.80% | 15,000 | $33K | New |
| AETHLON MEDICAL INC | 0.75% | 36,000 | $31K | New |
| HAOXI HEALTH TECHNOLOGY LTD | 0.04% | 10,000 | $2K | New |
Portfolio Sells Q3 2024 → Q4 2024
| AAPL Apple Inc. | Sold out | 0.00% | −56.55 |
| NVDA Nvidia Corp. | Sold out | 0.00% | −10.43 |
| TSLA Tesla Inc. | Sold out | 0.00% | −7.69 |
| ORCL Oracle Corp. | Sold out | 0.00% | −6.33 |
| SPY SS SPDR S&P 500 ETF Trust-US | Sold out | 0.00% | −4.99 |
| BANK MONTREAL QUE | Sold out | 0.00% | −2.38 |
| META Meta Platforms Inc. Class A | Sold out | 0.00% | −2.33 |
| VKTX Viking Therapeutics Inc. | Sold out | 0.00% | −1.84 |
| INTC Intel Corp. | Sold out | 0.00% | −1.36 |
| CVNA Carvana Co. | Sold out | 0.00% | −1.01 |
| GOOGL Alphabet Inc. Class A | Sold out | 0.00% | −0.91 |
| AMZN Amazon.com Inc. | Sold out | 0.00% | −0.81 |
| GE General Electric | Sold out | 0.00% | −0.66 |
| CAPR Capricor Therapeutics Inc. | Sold out | 0.00% | −0.56 |
| CGC Canopy Growth Corp. | Sold out | 0.00% | −0.16 |
| FANGDD NETWORK GROUP LTD | Sold out | 0.00% | −0.15 |
| MLGO Microalgo Inc. | Sold out | 0.00% | −0.02 |
Portfolio Buys Q3 2024 → Q4 2024
| QQQ Invesco QQQ Trust Series 1 | Add +330.8% | 69.21% | +67.37 |
| MRNA Moderna Inc. | New | 14.58% | +14.58 |
| CYBR Cyberark Software Ltd./Israel | New | 8.05% | +8.05 |
| X United States Steel Corp. | New | 6.57% | +6.57 |
| NRXP NRX Pharmaceuticals Inc. | New | 0.80% | +0.80 |
| AETHLON MEDICAL INC | New | 0.75% | +0.75 |
| HAOXI HEALTH TECHNOLOGY LTD | New | 0.04% | +0.04 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 32 | $226.8M | SNDK, AMD, INTC, MU, SPCX |
| Q1 2026 | 34 | $88.8M | GLD, NVDA, MU, SNDK, QQQ |
| Q4 2025 | 34 | $45.7M | QQQ, SPY, IBIT, GLD, AAPL |
| Q3 2025 | 37 | $224.4M | NVDA, PFE, HOOD, GLD, LLY |
| Q2 2025 | 38 | $159.6M | AAPL, MSTR, HOOD, QQQ, NVDA |
| Q1 2025 | 27 | $27.6M | AAPL, CVNA, NVDA, PLTR, META |
| Q4 2024 | 7 | $4.1M | QQQ, MRNA, CYBR, X, NRXP |
| Q3 2024 | 18 | $34.5M | AAPL, NVDA, TSLA, ORCL, SPY |
| Q2 2024 | 20 | $24.7M | QQQ, NVDA, SMH, SMCI, HUBS |
| Q1 2024 | 24 | $23.6M | NVDA, VKTX, IBIT, GLD, QQQ |